% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • robmengnny robmengnny Oct 11, 2012 11:05 AM Flag

    8 reasons---Aetna cannot do too much on 13th update

    1. Qcor provided more information to them to show the result of the study.
    2. Achar Gel's effectiveness has been approved by FDA. It's hard for Aetna to fight with FDA. It can QUESTION it , but it is no strong evidence to against using the drug, or the time is too early to deny FDA's approval.
    3. Aetna cannot find a right candidate to replace Achar Gel right away.
    4. Aetna questionnig two of the indications. It is not to deny all of them.
    5. Aetna's action already made the current patients worried about the policy. They question Aetna is looking for reasons to cut the reimbursement to relief its responsibility.
    6. Other insurance companies like UNH, Oxford are not really react to its chanllege. Thus, people more couriou the purpose that Aetna's action. Why only you jump out?
    7. If on 13th, Aetna really does something extrodinary, then the current patients would be filing the lawsuits--Why you cut it? Show me the authorized approved evidence! What about the doctors who recommended the usage and the Aetna doesn't approve, and patient died. What about the lawsuit follows, and doctors are in the court as a witness.....I don't think Aetna will take that kind of risk of lossing multimiliion dollars!---It's better pay for the bill now!
    8. In comparision with other insurance coverage, if Aetna does something extrodinary, then people will question about the quality of its service. We shall see more peole leaving Aetna because its poor service.

    So we can project that Aetna will not and cannot do too much on its 13th update.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
93.600.00(0.00%)Aug 14 4:00 PMEDT